Literature DB >> 9933454

A syndrome resembling human systemic sclerosis (scleroderma) in MRL/lpr mice lacking interferon-gamma (IFN-gamma) receptor (MRL/lprgammaR-/-).

M Le Hir1, M Martin, C Haas.   

Abstract

MRL/lpr mice develop a systemic autoimmune disease characterized by autoantibodies and inflammatory lesions in various organs. The main cause of early mortality is glomerulonephritis. We previously found that MRL/lprgammaR-/- mice are protected from glomerulonephritis and have an increased life span compared with their MRL/lprgammaR+/+ littermates. We now carried out a histopathological study of a selection of organs of MRL/lprgammaR-/- mice. Mice were killed as soon as they showed clinical signs of disease. In the majority of animals skin lesions were the first apparent pathology. Mononuclear cell infiltrates were frequent in skin, lungs and kidneys, and they occurred also in liver, salivary glands and heart. In infiltrated areas there was an abnormal accumulation of bundles of collagen. In the lungs of MRL/lprgammaR-/- mice, and occasionally in other organs, small and middle-sized arteries and veins showed intimal proliferation, resulting in a narrowed lumen. Alveolitis was widespread. Mononuclear cell infiltrates and excessive production of collagen in the skin and several visceral organs, thickening of vascular intima and autoantibodies are characteristic features of human systemic sclerosis. Thus, MRL/lprgammaR-/- mice might represent a model for that disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933454      PMCID: PMC1905153          DOI: 10.1046/j.1365-2249.1999.00808.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

Review 1.  The endothelium: its role in scleroderma.

Authors:  J D Pearson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

2.  In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.

Authors:  C Prior; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton.

Authors:  M C Green; H O Sweet; L E Bunker
Journal:  Am J Pathol       Date:  1976-03       Impact factor: 4.307

Review 4.  Interferons and collagen production.

Authors:  R D Granstein; T J Flotte; E P Amento
Journal:  J Invest Dermatol       Date:  1990-12       Impact factor: 8.551

Review 5.  Lymphokine control of in vivo immunoglobulin isotype selection.

Authors:  F D Finkelman; J Holmes; I M Katona; J F Urban; M P Beckmann; L S Park; K A Schooley; R L Coffman; T R Mosmann; W E Paul
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

6.  Dermatopathological studies on skin lesions of MRL mice.

Authors:  F Furukawa; H Tanaka; K Sekita; T Nakamura; Y Horiguchi; Y Hamashima
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

7.  Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities.

Authors:  J H Berden; L Hang; P J McConahey; F J Dixon
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

8.  Structural features of interstitial lung disease in systemic sclerosis.

Authors:  N K Harrison; A R Myers; B Corrin; G Soosay; A Dewar; C M Black; R M Du Bois; M Turner-Warwick
Journal:  Am Rev Respir Dis       Date:  1991-09

9.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Characterization of a spontaneous disease of white leghorn chickens resembling progressive systemic sclerosis (scleroderma).

Authors:  M E Gershwin; H Abplanalp; J J Castles; R M Ikeda; J van der Water; J Eklund; D Haynes
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Progress in systemic sclerosis: novel therapeutic paradigms.

Authors:  J Varga
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

Review 2.  T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

Authors:  C Chizzolini
Journal:  Springer Semin Immunopathol       Date:  1999

Review 3.  Animal models for scleroderma: an update.

Authors:  Yan Zhang; Anita C Gilliam
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

Review 4.  Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome.

Authors:  M R Kok; B J Baum; P P Tak; S R Pillemer
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 5.  Molecular pathogenesis of skin fibrosis: insight from animal models.

Authors:  Gideon P Smith; Edwin S L Chan
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

Review 6.  Animal Models of Systemic Sclerosis: Using Nailfold Capillaroscopy as a Potential Tool to Evaluate Microcirculation and Microangiopathy: A Narrative Review.

Authors:  Angélica Mandujano; Melissa Golubov
Journal:  Life (Basel)       Date:  2022-05-08

Review 7.  Mesenchymal stem cells in fibrotic diseases-the two sides of the same coin.

Authors:  Lei Qin; Nian Liu; Chao-le-Meng Bao; Da-Zhi Yang; Gui-Xing Ma; Wei-Hong Yi; Guo-Zhi Xiao; Hui-Ling Cao
Journal:  Acta Pharmacol Sin       Date:  2022-07-27       Impact factor: 7.169

8.  The role of B cells in systemic sclerosis.

Authors:  Marina D Kraaij; Jacob M van Laar
Journal:  Biologics       Date:  2008-09

Review 9.  Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart.

Authors:  Cinzia Perrino; Péter Ferdinandy; Hans E Bøtker; Bianca J J M Brundel; Peter Collins; Sean M Davidson; Hester M den Ruijter; Felix B Engel; Eva Gerdts; Henrique Girao; Mariann Gyöngyösi; Derek J Hausenloy; Sandrine Lecour; Rosalinda Madonna; Michael Marber; Elizabeth Murphy; Maurizio Pesce; Vera Regitz-Zagrosek; Joost P G Sluijter; Sabine Steffens; Can Gollmann-Tepeköylü; Linda W Van Laake; Sophie Van Linthout; Rainer Schulz; Kirsti Ytrehus
Journal:  Cardiovasc Res       Date:  2021-01-21       Impact factor: 10.787

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.